Announcements Trials
Browse Landscape

Phase

Phase 2 184Phase 1 93Phase 1/2 49Phase NA 23Phase 3 23Phase 4 10Phase 2/3 7Phase EARLY_PHASE1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Kidney Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

Magnetic Resonance Spectroscopy 59Cyclophosphamide 44pembrolizumab 34Radiotherapy 30fludarabine 27Nivolumab 26Biopsy 26Metformin 22Fluorodeoxyglucose F18 22Specimen Handling 20Bevacizumab 20Temozolomide 17Radiosurgery 17Cisplatin 16Carboplatin 14Fluorouracil 13Dexamethasone 13Paclitaxel 12Gemcitabine 12Etoposide 12gallium 68 PSMA-11 11durvalumab 11X-Rays 11Surgical Procedures, Operative 11Radiation 11Positron Emission Tomography Computed Tomography 11Letrozole 11Irinotecan 11Ipilimumab 11Surveys and Questionnaires 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Sorafenib × Clear all
NCT00405366 2017-04-18

NRR

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
30 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01337492 2012-03-21

Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT)

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Terminated
2 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡